transplant
First-of-its-kind data shows Novartis’ iscalimab extends survival of transplanted kidneys
June 6, 2019Research and Development Novartis, iscalimab, kidney transplant, pharma, transplant
In a first-of-its-kind reveal, Novartis has presented histology data for iscalimab (CFZ533) at the American Transplant Congress (ATC) which indicates …
MSD’s antiviral drug hits endpoint targets in Phase III trials
October 20, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant
MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …
European approval for BMS kidney transplant drug Nulojix
June 22, 2011Sales and Marketing BMS, EMA, Nulojix, transplant
European regulators have followed their US counterparts in granting marketing authorisation for a drug which aims to prevent kidney transplant …
